
Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.
Matthew Hewitt is vice-president, technical officer, Cell & Gene Therapy & Biologics, at Charles River Laboratories.

Published: December 6th 2023 | Updated:

Published: November 2nd 2023 | Updated: